Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States.
Arrowhead Pharmaceuticals stock last closed at $73.95, down 3.55% from the previous day, and has increased 369.82% in one year. It has overperformed other stocks in the Biotechnology industry by 4.47 percentage points. Arrowhead Pharmaceuticals stock is currently +417.13% from its 52-week low of $14.30, and -9.82% from its 52-week high of $82.00.
There are currently 140.86M shares of ARWR outstanding. The market capitalization of ARWR is $10.42B. In the past 24 hours, 1.51M ARWR shares were traded.
How to Buy Arrowhead Pharmaceuticals Stock
Wondering how to invest in Arrowhead Pharmaceuticals stock? Here's how.
Decide where to buy Arrowhead Pharmaceuticals stock: You need to choose a stock brokerage, but don't worry - we've tested dozens of online stock brokerages and apps to help you decide where to buy Arrowhead Pharmaceuticals stock.
Create your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
Deposit funds into your investment account: Select your payment method and add your information.
Analyze Arrowhead Pharmaceuticals stock: The Arrowhead Pharmaceuticals ticker symbol is ARWR. Is Arrowhead Pharmaceuticals stock a good investment? Should you buy shares of ARWR? How do ARWR's underlying business fundamentals look? Do top analysts think Arrowhead Pharmaceuticals is a good buy? Why has ARWR's stock price moved recently? (Hint: Our stock market analysis tools can help you evaluate if ARWR is a good stock to buy).
Execute your ARWR buy order: Decide if you will purchase ARWR shares at the current market price or use a limit order to buy ARWR shares at a specific price.
Track your investment in ARWR: Create a watchlist to important updates regarding your new investment in Arrowhead Pharmaceuticals stock.
Step 1: Decide where to buy Arrowhead Pharmaceuticals stock
You need an online brokerage account in order to access the NASDAQ market and buy ARWR shares.
A brokerage account is an investment account that allows you to buy and sell a variety of financial instruments, including stocks, bonds, mutual funds, and ETFs.
Our preferred brokerage: eToro
In our opinion, eToro is the best stock brokerage. Here's why:
You can invest in stocks with zero commissions: Invest without paying trading commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
Access to global financial markets: From Technology to Real Estate, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading exchanges.
Social investing: eToro has a community of more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of other investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by opening an account with eToro now. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Create your brokerage account
Now that you've picked the right brokerage, you need to fill out some personal info so you are able to invest in ARWR today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Analyze Arrowhead Pharmaceuticals stock
After you have decided on the best place to buy Arrowhead Pharmaceuticals stock, it's crucial to evaluate their stock before you invest, so you actually comprehend the risk as well as the opportunity.
Arrowhead Pharmaceuticals Numbers
ARWR Price
$73.95
1w %
-4.88%
1y %
369.82%
5y %
2.34%
P/E
-34.4x
P/B
16.97x
P/S
16.93x
PEG
N/A
Revenue
$622.01M
Earnings
-$300.91M
Fore. Rev. Growth
-6.35%
Fore. Earn. Growth
N/A
Market Cap
$10.42B
Next Earnings
N/A
Next Dividend
N/A
ARWR Overview
WallStreetZen was designed to help average investors do better fundamental analysis in minutes instead of hours.
There are more short-term assets than long-term liabilities on the ARWR balance sheet.
There are more short-term assets than short-term liabilities on the ARWR balance sheet.
ARWR has cash burn of 50872000. It has sufficient cash and short-term investments to cover this for at least one year.
ARWR has $1.78B in cash and short term investments. This is sufficient to cover its annual cash burn of $50.87M.
Negative Financial Indicators:
Total ARWR debt is higher than 5 years ago, relative to shareholder equity.
ARWR profit margin has gone down from -26.4% to -48.4% in the past year.
ARWR has a relatively high debt to equity ratio of 2.72.
Do Wall Street analysts think it's a good time to buy ARWR stock
Out of 10 Wall Street analysts who give recommendations on ARWR, the consensus analyst rating on ARWR is a Strong Buy
It's important to note that analyst forecasts are not recommendations, nor are they financial advice.
Latest ARWR Analyst Recommendations
Madison El-Saadi, a top 27% analyst from B. Riley Securities maintains ARWR with a strong buy rating and raises their ARWR price target from $61.00 to $101.00, on Jan 22, 2026.
Edward Tenthoff, a bottom 2% analyst from Piper Sandler reiterates ARWR with a strong buy rating and raises their ARWR price target from $100.00 to $110.00, on Jan 13, 2026.
Andrea Tan, a bottom 3% analyst from Goldman Sachs maintains ARWR with a hold rating and raises their ARWR price target from $50.00 to $85.00, on Jan 7, 2026.
Keay Nakae, a top 5% analyst from Chardan Capital maintains ARWR with a strong buy rating and raises their ARWR price target from $60.00 to $80.00, on Jan 7, 2026.
Jason Gerberry, a top 12% analyst from Bank of America maintains ARWR with a strong buy rating and raises their ARWR price target from $62.00 to $81.00, on Dec 9, 2025.
Last year, ARWR revenue was $622.01M. Over the last 5 year, ARWR's revenue has gone up by 47.49% per year. This was faster than the Biotechnology industry average of 29.75%.
No, Arrowhead Pharmaceuticals doesn't provide an income stream by paying out dividends.
ARWR Social Trading Data
One of the biggest reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other community members have to say.
Step 5: Execute your ARWR buy order
There are two main options:
Market order: A market order is an order to buy or sell a stock at the best price on the market. Market orders are mostly the best for newer investors.
Limit order: A limit order allows you to buy or sell a stock at a specific price (or better). If you want to be certain you're buying or selling at a specific price, use a limit order.
Click the Open Trade button and eToro will place your order.
If you need additional help with buying stocks on eToro, watch the helpful video below:
How much does it cost to buy one Arrowhead Pharmaceuticals share?
As of May 18, 2026, it costs $73.95 to buy one share of Arrowhead Pharmaceuticals stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.135 shares of ARWR.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.